Sensory neurons display cell-type-specific vulnerability to loss of neuron-glia interactions is a research paper published in Cell Reports (2022). On theSindex it has a DataRank of 0. It has been cited 19 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute on Drug Abuse
Grant: DP1DA054343
Burroughs Wellcome Fund
Grant: R01NS119476
Burroughs Wellcome Fund
Grant: K08NS101064
U.S. Department of Defense
Grant: R35NS105076
U.S. Department of Defense
Grant: W81XWH2210386
National Multiple Sclerosis Society
Grant: RG-1807-32005
National Institutes of Health
Grant: 1RF1AG072080
National Institutes of Health
Grant: R01NS099334
National Institutes of Health
Grant: R01NS109372
National Institutes of Health
Grant: R01NS067550
NINDS NIH HHS
Grant: R01 NS034939
NIA NIH HHS
Grant: K08 AG065463
NICHD NIH HHS
Grant: P50 HD105351
NIA NIH HHS
Grant: R01 AG072080
NIA NIH HHS
Grant: RF1 AG072080
National Institutes of Health
Grant: 1K08NS101064-01
Control of long gene expression as a novel therapeutic approach for Rett syndrome
National Institutes of Health
Grant: 5R35NS105076-04
Unravelling mechanisms and novel therapeutic targets for peripheral neuropathy and neuropathic pain
National Institutes of Health
Grant: 1RF1AG072080-01
Exploring the origins of myelin abnormalities in normal ageing and in vascular dementia
National Institutes of Health
Grant: 5R01NS119476-02
Next Generation Gene Therapy for Refractory Pain
National Institutes of Health
Grant: 5DP1DA054343-04
Epigenomic labeling of cells that drive drug abuse behavior
National Institutes of Health
Grant: 7R01NS109372-03
Reversible mRNA methylation in oligodendrocyte development and CNS myelination
National Institutes of Health
Grant: 5R01NS099334-04
Regulation of CD4+ T cell-mediated Demyelination Following Oligo Ablation
National Institutes of Health
Grant: 5R01NS067550-04
ZFP191 control of the myelination program of oligodendrocytes
Teva Pharmaceutical Industries
University of California, Los Angeles
Burroughs Wellcome Fund
Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
FWCI
1.83
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals